Piermont Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-16,530
| Closed | -$119K | – | 244 |
|
|
2018
Q1 | $119K | Sell |
16,530
-2,600
| -14% | -$18.7K | 0.04% | 236 |
|
|
2017
Q4 | $156K | Sell |
19,130
-1,070
| -5% | -$8.73K | 0.05% | 236 |
|
|
2017
Q3 | $293K | Sell |
20,200
-20,218
| -50% | -$293K | 0.1% | 220 |
|
|
2017
Q2 | $489K | Sell |
40,418
-7,200
| -15% | -$87.1K | 0.14% | 229 |
|
|
2017
Q1 | $612K | Buy |
+47,618
| New | +$612K | 0.15% | 214 |
|